Study: Review of CBD for treatment-resistant epilepsy

This recent clinical trial concerning cannabidiol (CBD) and seizure disorders demonstrated that “CBD might reduce seizure frequency and an adequate safety profile in children and young adults with highly treatment-resistant epilepsy.” In 2016, doctors across the United States began an open-label interventional trial focused on patients (aged 1–30 years) with severe, intractable, childhood-onset, treatment-resistant epilepsy. These patients were all receiving stable doses of anti-epileptic medications prior to study entry and were enrolled in an expanded-access program at 11 epilepsy cente...
More

Study: Marijuana Dependence

According to Dr. David Bearman, cannabis is "one of the safest therapeutic agents known to man, even safer than eating ten potatoes." This was further supported by Dr. Jack E. Henningfield and Dr. Neal L. Benowitz, two well-known addictionologists located at the National Institute on Drug Abuse and University of California at San Francisco, respectively. Both physicians concluded that cannabis is less dangerous than caffeine. This was determined by ranking five psychoactive substances on the following five criteria: withdrawal, reinforcement, tolerance, dependence, and intoxication. Further, ...
More